FTUS
IBB icon

Flow Traders U.S.’s iShares Biotechnology ETF IBB Stock Holding History

Flow Traders U.S.’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,708
Closed -$3.5M – 1181
2026
Q1 		$3.5M Buy
20,708
+13,701
+196% +$2.34M 0.11% 155
2025
Q4 		$1.18M Sell
7,007
-23,069
-77% -$3.75M 0.04% 348
2025
Q3 		$4.34M Buy
+30,076
New +$4.11M 0.18% 111
2025
Q2 		– Sell
-9,207
Closed -$1.18M – 1075
2025
Q1 		$1.18M Sell
9,207
-6,965
-43% -$944K 0.05% 350
2024
Q4 		$2.14M Buy
+16,172
New +$2.27M 0.09% 199
2024
Q3 		– Sell
-13,575
Closed -$1.86M – 1010
2024
Q2 		$1.86M Sell
13,575
-9,227
-40% -$1.23M 0.09% 201
2024
Q1 		$3.13M Buy
22,802
+20,459
+873% +$2.79M 0.17% 113
2023
Q4 		$318K Sell
2,343
-19,500
-89% -$2.38M 0.01% 599
2023
Q3 		$2.67M Buy
+21,843
New +$2.78M 0.13% 152
2023
Q2 		– Sell
-24,130
Closed -$3.12M – 971
2023
Q1 		$3.12M Buy
+24,130
New +$3.16M 0.13% 122
2022
Q4 		– Sell
-13,123
Closed -$1.53M – 981
2022
Q3 		$1.53M Buy
+13,123
New +$1.63M 0.08% 230
2021
Q4 		– Sell
-23,294
Closed -$3.77M – 905
2021
Q3 		$3.77M Buy
+23,294
New +$3.92M 0.15% 119
2021
Q2 		– Sell
-15,846
Closed -$2.44M – 1019
2021
Q1 		$2.39M Buy
15,846
+8,986
+131% +$1.43M 0.13% 159
2020
Q4 		$1.04M Sell
6,860
-28,238
-80% -$4.04M 0.07% 231
2020
Q3 		$4.75M Buy
+35,098
New +$4.76M 0.35% 54
2017
Q4 		– Sell
-2,361
Closed -$263K – 208
2017
Q3 		$263K Buy
+2,361
New +$252K 0.03% 174
2017
Q2 		– Sell
-2,121
Closed -$207K – 273
2017
Q1 		$207K Buy
2,121
+1,863
+722% +$178K 0.02% 289
2016
Q4 		$23K Sell
258
-42
-14% -$3.82K ﹤0.01% 383
2016
Q3 		$29K Buy
+300
New +$28.5K ﹤0.01% 301
2014
Q4 		– Sell
-8,748
Closed -$798K – 204
2014
Q3 		$798K Buy
+8,748
New +$768K 0.1% 69

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Flow Traders U.S.'s IBB Position: Q2 2026 in Review

Flow Traders U.S. sold out of iShares Biotechnology ETF (IBB) in Q2 2026, closing a stake of 20,708 shares — an estimated $3.5M sold.

Flow Traders U.S. first reported a position in IBB in Q3 2014 and held it in 20 quarters. The position peaked at $4.75M in Q3 2020. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Flow Traders U.S. reported no remaining iShares Biotechnology ETF position as of Q2 2026 after selling out during the quarter.
  • Flow Traders U.S. sold 20,708 iShares Biotechnology ETF shares in Q2 2026, an estimated $3.5M.
  • Flow Traders U.S. first reported a position in iShares Biotechnology ETF in Q3 2014 and held it in 20 quarters.
  • Flow Traders U.S.'s iShares Biotechnology ETF position peaked at $4.75M in Q3 2020.
  • 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Flow Traders U.S.'s 13F filing for Q2 2026, filed 14 Aug 2026.